Peihua Lu

机构：Luye Pharma (China), Beijing Dao Pei Hospital, Wuxi People's Hospital, China Agricultural University · ORCID：0000-0002-6331-7369

发表论文 135 篇 · 总被引 2562 次 · h-index 23

代表论文

• Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia (2024 · Blood · 被引 46)
• Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40–50: A CBMTR Registry-based propensity score matching analysis over the last decade (2025 · Cancer Letters · 被引 15)
• Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma (2025 · Blood Advances · 被引 7)
• Epidemiology, clinical features, and molecular basis of TTMV :: RARA -driven acute promyelocytic leukemia (2025 · Blood · 被引 5)
• China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024) (2025 · Blood Science · 被引 3)
• Clinical outcomes of offspring and matched unrelated donor transplants in relapsed or refractory severe aplastic anemia patients aged 40–50: a retrospective analysis from the CBMTR over the past decade (2025 · Bone Marrow Transplantation · 被引 2)